PREVALENCE OF MUTATIONS IN EGFR, KRAS AND BRAF IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) AS ASSESSED BY A PANEL OF PCR-BASED ASSAYS

被引：0
作者：
O'Donnell, Patrick
Current, Robert
Ferguson, Jane
Chien, Shih-Chang
Wen, Wei
Tsan, Alison
Newton, Nick
Jung, Laura
Bauer, Keith
Langland, Rachel
Brophy, Victoria
Schoenbrunner, Nancy
Myers, Thomas
Soviero, Stephen
Lawrence, Jeffrey
Wu, Lin
机构：
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
EGFR mutations; Kras mutations; BRAF mutations; molecular diagnostics;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1533 / S1534
页数：2
相关论文
共 50 条
  • [41] Biochip-Based Detection of KRAS Mutation in Non-Small Cell Lung Cancer
    Kriegshaeuser, Gernot
    Fabjani, Gerhild
    Ziegler, Barbara
    Zoechbauer-Mueller, Sabine
    End, Adelheid
    Zeillinger, Robert
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2011, 12 (12) : 8530 - 8538
  • [42] KRAS mutations testing in non-small cell lung cancer: the role of Liquid biopsy in the basal setting
    Nacchio, Mariantonia
    Sgariglia, Roberta
    Gristina, Valerio
    Pisapia, Pasquale
    Pepe, Francesco
    De Luca, Caterina
    Migliatico, Ilaria
    Clery, Eduardo
    Greco, Lorenza
    Vigliar, Elena
    Bellevicine, Claudio
    Russo, Antonio
    Troncone, Giancarlo
    Malapelle, Umberto
    JOURNAL OF THORACIC DISEASE, 2020, 12 (07) : 3836 - 3843
  • [43] Cell-Free Tumor DNA (ctDNA) Utility in Detection of Original Sensitizing and Resistant EGFR Mutations in Non-Small Cell Lung Cancer (NSCLC)
    Agulnik, Jason S.
    Papadakis, Andreas I.
    Pepe, Carmela
    Sakr, Lama
    Small, David
    Wang, Hangjun
    Kasymjanova, Goulnar
    Spatz, Alan
    Cohen, Victor
    CURRENT ONCOLOGY, 2022, 29 (02) : 1107 - 1116
  • [44] Prognostic and Predictive Role of KRAS-Mutations in Patients with Advanced Non-Squmous Non-Small-Cell Lung Cancer (NS-NSCLC)
    Sanchez-Salinas, Mario A.
    Garde-Noguera, Javier
    Sanchez, Jose Garcia
    Valera, Marisol
    Marin, Sara
    Hidalgo, Julia
    Arturo Albino, Rene
    Ferrando Marco, Jose
    Llombart Cussac, Antonio
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S454 - S454
  • [45] Prevalence of ROS1, HER2, and BRAF Alterations in a Cohort of Advanced Non-Small Cell Lung Cancer (NSCLC) Patients (P) Triple Negative (TN)
    Moran, Teresa
    Carcereny, Enric
    Terrasa, Josefa
    Marse, Raquel
    Estival, Ana
    Guillot, Monica
    Vila, Laia
    De Los Llanos Gil, Maria
    Hardy-Weber, Max
    Teruel, Iris
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S704 - S704
  • [46] KRAS and the Reality of Personalized Medicine in Non-Small Cell Lung Cancer
    Havva O Kilgoz
    Guzide Bender
    Joseph M Scandura
    Agnes Viale
    Bahar Taneri
    Molecular Medicine, 2016, 22 : 380 - 387
  • [47] Performance of a Rapid Digital PCR Test for the Detection of Non-Small Cell Lung Cancer (NSCLC) Variants
    Al Mana, Abdulaziz F.
    Culp, Kristen
    Keeler, Abby
    Perrera, Orlando
    Rajagopalan, Malini
    Jacky, Lucien
    Brown, Brad
    Thyagarajan, Bharat
    MOLECULAR DIAGNOSIS & THERAPY, 2024, : 791 - 802
  • [48] Role of the dynamic tumor microenvironment in controversies regarding immune checkpoint inhibitors for the treatment of non-small cell lung cancer (NSCLC) with EGFR mutations
    Anqi Lin
    Ting Wei
    Hui Meng
    Peng Luo
    Jian Zhang
    Molecular Cancer, 18
  • [49] Role of the dynamic tumor microenvironment in controversies regarding immune checkpoint inhibitors for the treatment of non-small cell lung cancer (NSCLC) with EGFR mutations
    Lin, Anqi
    Wei, Ting
    Meng, Hui
    Luo, Peng
    Zhang, Jian
    MOLECULAR CANCER, 2019, 18 (01)
  • [50] Value of serum tumor markers for predicting EGFR mutations in non-small cell lung cancer patients
    Wen, Linfang
    Wang, Shenghao
    Xu, Weiran
    Xu, Xiaofeng
    Li, Mei
    Zhang, Yaqiong
    Du, Xiaobing
    Liu, Shuang
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2020, 49
12345